Combat Cancer

About Combat Cancer

Combat Cancer develops patented hyperthermic technologies for cancer treatment, focusing on bladder and peritoneal cancers. Its devices are used in hospitals around the world and the company maintains a global network of distributors, extensive clinical trials, and ongoing research to validate efficacy across multiple countries. With headquarters and operations tied to Combat Medical Group, it emphasizes evidence-based practice and collaboration with healthcare professionals to advance hyperthermic cancer therapies.